Literature DB >> 10729714

Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits.

X Shuhua1, Y Jiqing, M Jinying, G Huifang, J Peiying, M Tanner.   

Abstract

The efficacy of combined treatment with praziquantel and artemether against infection with Schistosoma japonicum was tested on infected rabbits, in which 7-to 14-day-old schistosomules and 42-day-old adult schistosomes were simultaneously present. Rabbits were treated orally with praziquantel and artemether using various dosages and schedules. The therapeutic effects were evaluated by estimating the mean total worm burden (TWB) and female worm burden (FWB) and comparing them with the worm burdens in control animals treated with praziquantel or artemether alone. When the rabbits received praziquantel in a single dose (50 mg/kg), or daily for 2-6 days (30-60 mg/kg), the TWB was reduced by 28-66% and the FWB by 26-65%. In rabbits treated with artemether the reductions were 44-56% and 35-54%, respectively. Treatment with praziquantel in combination with artemether resulted in a significantly greater reduction of worm burden than was found for the groups treated with praziquantel or artemether alone, using the same dosages and schedules. TWB was reduced by 79-92%, and FWB by 80-93%. The results demonstrated that when rabbits infected simultaneously with schistosomules and adult schistosomes were treated with praziquantel in combination with artemether, the effects of the individual drugs could be increased significantly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729714     DOI: 10.1016/s1383-5769(00)00029-5

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  13 in total

Review 1.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 2.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Artemether treatment of prepatent Schistosoma japonicum induces resistance to reinfection in association with reduced pathology.

Authors:  Paul B Bartley; Amber Glanfield; Yuesheng Li; Danielle I Stanisic; Mary Duke; Malcolm K Jones; Donald P McManus
Journal:  Am J Trop Med Hyg       Date:  2008-06       Impact factor: 2.345

4.  A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China.

Authors:  Xun-Ya Hou; Donald P McManus; Darren J Gray; Julie Balen; Xin-Song Luo; Yong-Kang He; Magda Ellis; Gail M Williams; Yue-Sheng Li
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

Review 5.  The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis.

Authors:  Philip Erik Wikman-Jorgensen; César Augusto Henríquez-Camacho; Sergio Serrano-Villar; Jose Antonio Pérez-Molina
Journal:  Pathog Glob Health       Date:  2012-11       Impact factor: 2.894

6.  Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2009-10-02       Impact factor: 2.289

Review 7.  Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.

Authors:  Shu-hua Xiao
Journal:  Parasitol Res       Date:  2013-08-27       Impact factor: 2.289

8.  An artemisinin derivative of praziquantel as an orally active antischistosomal agent.

Authors:  Lanlan Dong; Wenwen Duan; Jinglei Chen; Huan Sun; Chunhua Qiao; Chao-ming Xia
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

Review 9.  Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.

Authors:  Maria João Gouveia; Paul J Brindley; Fátima Gärtner; José M Correia da Costa; Nuno Vale
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-05

Review 10.  Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?

Authors:  R Alan Wilson; Xiao-Hong Li; William Castro-Borges
Journal:  Parasit Vectors       Date:  2016-02-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.